Generate Biomedicines Accounts Payable

Generate Biomedicines (GENB) currently reports a accounts payable of $7.6M as of March 2026. Use the charts on this page to explore Generate Biomedicines's accounts payable history and peer comparisons.

Generate Biomedicines reported $7.6M in accounts payable as of March 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $7.6M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Generate Biomedicines, and consider following GENB for alerts when major investors trade the stock.